PEDMARK® REDUCED THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH HEPATOBLASTOMA, SEEN IN A TURKISH COMPASSIONATE USE TREATMENT PROTOCOL

Basit Öğe Kaydı
dc.contributor.authorCabi, Emel Unal
dc.contributor.authorTacyildiz, Nurdan
dc.contributor.authorAtaseven, Eda
dc.contributor.authorSivrice, Ayse Cigdem
dc.contributor.authorSevinir, Betul
dc.contributor.authorBrock, Penelope
dc.contributor.authorBhattacharya, Ananya
dc.date.accessioned2024-08-31T07:50:57Z
dc.date.available2024-08-31T07:50:57Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstract[Abstarct Not Available]en_US
dc.identifier.endpageS573en_US
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.startpageS572en_US
dc.identifier.urihttps://hdl.handle.net/11454/105430
dc.identifier.volume70en_US
dc.identifier.wosWOS:001183650902354en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Blood & Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240831_Uen_US
dc.titlePEDMARK® REDUCED THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH HEPATOBLASTOMA, SEEN IN A TURKISH COMPASSIONATE USE TREATMENT PROTOCOLen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu